Search
for
Sort by
Research 30 of 1000+
- Lifestyle Drugs
- Lifestyle Drugs in Old Age – A Mini-Review
- Lifestyle drugs: concept and impact on society
- New lifestyle drugs and somatoform disorders in dermatology
- A History of Drug Advertising: The Evolving Roles of Consumers and Consumer Protection
- Lifestyle intervention and anti-obesity therapies in the polycystic ovary syndrome: impact on metabolism and fertility
- The Effects of Changing Lifestyle and Daily Behaviours in the First Months of COVID-19 Outbreak on Dermatological Diseases: Retrospective Cross-Sectional Observational Study
- Chronic inflammatory diseases are stimulated by current lifestyle: how diet, stress levels and medication prevent our body from recovering
- Pharma in the bedroom . . . and the kitchen. . . . The pharmaceuticalisation of daily life
- Targets to treat androgen excess in polycystic ovary syndrome
- Ovarian Hypertension: Polycystic Ovary Syndrome
- Androgenetic Alopecia From A to Z
- Polycystic Ovary Syndrome in adolescents: an update
- THERAPY OF ENDOCRINE DISEASE: Treatment of hirsutism in the polycystic ovary syndrome
- New drugs: Agalsidase beta
- New drugs: Iobenguane sulfate
- New drugs: Agalsidase alfa
- A Review on Herbal Drugs Used For Hair Growth Promotion
- Infertility in Women with Polycystic Ovary Syndrome
- CURRENT THERAPEUTIC APPROACHES IN THE MANAGEMENT OF POLYCYSTIC OVARY SYNDROME
- Controversy: is there a role for adjuvants in the management of male pattern hair loss?
- Current aspects of polycystic ovary syndrome II: treatment of hyperandrogenism, insulin resistance and infertility
- Therapeutic approach for metabolic disorders and infertility in women with PCOS
- Hirsutism in young women
- Conventional treatments in systemic lupus erythematosus
- Impact of Reducing Obesity in PCOS: Methods and Treatment Outcomes
- Premature graying of hairs: Ayurveda perspective
- Polycystic ovary syndrome [PCOS]: Comprehensive management in primary care
- Insulin resistance and the long-term consequences of polycystic ovary syndrome
- Metabolic syndrome – a new definition and management guidelines A joint position paper by the Polish Society of Hypertension, Polish Society for the Treatment of Obesity, Polish Lipid Association, Polish Association for Study of Liver, Polish Society of Family Medicine, Polish Society of Lifestyle Medicine, Division of Prevention and Epidemiology Polish Cardiac Society, “Club 30” Polish Cardiac Society, and Division of Metabolic and Bariatric Surgery Society of Polish Surgeons